TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17079377

Group type: EXPERIMENTAL
Intervention: Alumina-on-alumina bearing system
Number of subjects: 146

Group type: COMPARATOR
Intervention: Cobalt-chromium-on-polyethylene bearing system
Number of subjects: 146
Study: 15580320

Group type: EXPERIMENTAL
Intervention: Cardiac troponin I (cTnI)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Cardiac troponin T (cTnT)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Both troponins (cTnI and cTnT)
Number of subjects: 119
Study: 11375376

Group type: EXPERIMENTAL
Intervention: epalrestat (150 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 9261853

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone (10 mg/kg/day for 10 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8300814

Group type: COMPARATOR
Intervention: FSH‐HP preparation (sp. act. approximately 9000 IU FSH/mg of protein), administered as a single dose of 150 IU by i.v. injection to females and by i.m. and s.c. routes to males.
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard urinary FSH preparation (Metrodin), administered as a single dose of 150 IU by i.v. injection to females and by i.m. and s.c. routes to males.
Number of subjects: 24
Study: 3446307

Group type: EXPERIMENTAL
Intervention: Half-dose flupenthixol decanoate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-dose flupenthixol decanoate
Number of subjects: 0
Study: 29048235

Group type: EXPERIMENTAL
Intervention: Random practice condition
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Constant practice condition
Number of subjects: 45

Group type: COMPARATOR
Intervention: Blocked practice condition
Number of subjects: 45
Study: 26713491

Group type: EXPERIMENTAL
Intervention: Cardiac telerehabilitation program (CTR) with individualized 3-month rehabilitation plan, home monitoring of blood pressure, pulse, weight, and steps taken.
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (standard rehabilitation activities).
Number of subjects: 151
Study: 24096802

Group type: EXPERIMENTAL
Intervention: Behavioral training with a commercial MRI simulator
Number of subjects: 222

Group type: COMPARATOR
Intervention: Behavioral training with an inexpensive mock scanner
Number of subjects: 222
Study: 24341465

Group type: EXPERIMENTAL
Intervention: Nothing Ventured Nothing Gained online adolescent and parenting intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 120
Study: 20619405

Group type: EXPERIMENTAL
Intervention: Water method (n = 42)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Air method (n = 40)
Number of subjects: 82
Study: 18845806

Group type: EXPERIMENTAL
Intervention: High-dose allopurinol (300 mg once a day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Low-dose allopurinol (100 mg once a day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 16339220

Group type: EXPERIMENTAL
Intervention: Clarithromycin 500 mg/day for 2 weeks
Number of subjects: 4373

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4373
Study: 12652225

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac tromethamine
Number of subjects: 114

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 114
Study: 10569560

Group type: EXPERIMENTAL
Intervention: 10 mg avorelin subcutaneous depot
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 mg avorelin subcutaneous depot
Number of subjects: 60
Study: 8758317

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (75 mg daily, n = 40)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (n = 44)
Number of subjects: 84
Study: 2071786

Group type: EXPERIMENTAL
Intervention: Inhaled histamine
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Exercise on a treadmill
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Asymptomatic individuals
Number of subjects: 527

Group type: EXPERIMENTAL
Intervention: Asthma subgroup
Number of subjects: 527
Study: 6753112

Group type: EXPERIMENTAL
Intervention: Pirenzepine 0.1 mg.kg-1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pirenzepine 0.25 mg.kg-1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pirenzepine 0.5 mg.kg-1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (0 mg.kg-1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pirenzepine (various doses)
Number of subjects: 8
Study: 31078402

Group type: EXPERIMENTAL
Intervention: BCAA-enriched dialysis fluid
Number of subjects: 6

Group type: COMPARATOR
Intervention: Standard high-flux HD
Number of subjects: 6
Study: 29042241

Group type: EXPERIMENTAL
Intervention: Monolithic zirconia crowns
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metal-ceramic crowns
Number of subjects: 30

Group type: COMPARATOR
Intervention: Enamel controls
Number of subjects: 30
Study: 27029956

Group type: COMPARATOR
Intervention: Kinesio Taping (KT)
Number of subjects: 44
Study: 24800828

Group type: EXPERIMENTAL
Intervention: Bivalent killed whole-cell oral cholera vaccine
Number of subjects: 137

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study: 22222120

Group type: EXPERIMENTAL
Intervention: Taiji practice
Number of subjects: 70

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 70
Study: 20008945

Group type: EXPERIMENTAL
Intervention: Medical care management intervention
Number of subjects: 407

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 407
Study: 18029497

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no fish oil supplementation)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (subgroup analysis)
Number of subjects: 0
Study: 16044225

Group type: EXPERIMENTAL
Intervention: Nasopharyngoscopy
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Auditory examination
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Visual and auditory evaluations
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Evaluation by less experienced raters
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cohens Kappa coefficient
Number of subjects: 12
Study: 11907287

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone
Number of subjects: 347

Group type: COMPARATOR
Intervention: Intravenous lidocaine
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (for patients with dispatch to drug administration ≤ 24 minutes)
Number of subjects: 347

Group type: COMPARATOR
Intervention: Intravenous lidocaine (for patients with dispatch to drug administration ≤ 24 minutes)
Number of subjects: 347
Study: 9464213

Group type: EXPERIMENTAL
Intervention: 50 micrograms of CCK‐4
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80
Study: 8582218

Group type: EXPERIMENTAL
Intervention: Serum gastrin measurement
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Basic acid output (BAO) measurement
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Free portal pressure (FPP) measurement
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gastroduodenoscopy and barium series
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gastroduodenoscopy
Number of subjects: 24
Study: 2746444

Group type: EXPERIMENTAL
Intervention: Chlorhexidine spray, applied twice a day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash, rinsed twice a day
Number of subjects: 14
Study: 769242

Group type: EXPERIMENTAL
Intervention: S-carboxymethylcysteine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31437399

Group type: EXPERIMENTAL
Intervention: Computational approach using nudged elastic band (NEB) and harmonic Fourier beads (HFB) methods for studying loop dynamics.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescence anisotropy measurements.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluorescence T-jump measurements.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predicted Trp354 conformational conversion associated with loop movements.
Number of subjects: 0
Study: 27686946

Group type: EXPERIMENTAL
Intervention: Temozolomide chemotherapy (75 mg/m2 once daily for 21 days, repeated every 28 days for a maximum of 12 cycles)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Radiotherapy (up to 50.4 Gy; 28 doses of 1.8 Gy once daily, 5 days per week for up to 6.5 weeks)
Number of subjects: 477

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Temozolomide chemotherapy
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 477
Study: 25027459

Group type: EXPERIMENTAL
Intervention: Triclosan coated sutures
Number of subjects: 2400

Group type: COMPARATOR
Intervention: Standard non-coated sutures
Number of subjects: 2400
Study: 22343176

Group type: EXPERIMENTAL
Intervention: Azidothymidine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 64
Study: 20696729

Group type: EXPERIMENTAL
Intervention: Early transition group (transferred from incubator to open crib at >1600 g)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard transition group (transferred from incubator to open crib at >1800 g)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Early transition group
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard transition group
Number of subjects: 94
Study: 18463880

Group type: EXPERIMENTAL
Intervention: Iridology assessment of patients with colorectal cancer
Number of subjects: 58

Group type: COMPARATOR
Intervention: Iridology assessment of healthy control subjects
Number of subjects: 58
Study: 16313106

Group type: EXPERIMENTAL
Intervention: Jiangni Hewei Decoction (JHD), one dose per day for 8 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Omeprazole, 20 mg once per day for 8 weeks
Number of subjects: 75
Study: 12893712

Group type: EXPERIMENTAL
Intervention: High sodium concentration (680 mg/l)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low sodium concentration (410 mg/l)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Water (no sodium)
Number of subjects: 13
Study: 9457940

Group type: EXPERIMENTAL
Intervention: T (50‐100 mg IM weekly) + desogestrel (150‐300 microg daily)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: T (50‐100 mg IM weekly) + levonorgestrel (125‐250 microg daily)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 15
Study: 1907565

Group type: EXPERIMENTAL
Intervention: TRH
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study: 6310812

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus radiotherapy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Both treatment arms
Number of subjects: 37
Study: 30677095

Group type: EXPERIMENTAL
Intervention: Abdominal belt wearing group (B)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-abdominal belt wearing control group (C)
Number of subjects: 36
Study: 30134976

Group type: EXPERIMENTAL
Intervention: Suite of videos for advance care planning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dynamic adaptations to implementation approach
Number of subjects: 0
Study: 27113442

Group type: EXPERIMENTAL
Intervention: telephone-delivered cognitive behavioural therapy (tCBT)
Number of subjects: 473

Group type: COMPARATOR
Intervention: usual care
Number of subjects: 473
Study: 24246900

Group type: EXPERIMENTAL
Intervention: Anonymous consent condition
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Quasi-anonymous consent condition
Number of subjects: 200

Group type: COMPARATOR
Intervention: Traditional consent condition
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Certificates of Confidentiality (CoC) condition
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Emotional distress disclosure
Number of subjects: 200
Study: 23366836

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 5

Group type: COMPARATOR
Intervention: sham-tDCS
Number of subjects: 5
Study: 20717108

Group type: EXPERIMENTAL
Intervention: Succinylated gelatin (SG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (NS)
Number of subjects: 80
Study: 17729384

Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation (HoLEP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transurethral resection (TURP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HoLEP and TURP
Number of subjects: 0
Study: 15713598

Group type: EXPERIMENTAL
Intervention: Gemcitabine 1,000 mg/m² on days 1, 8, and 15 of each 28-day cycle (3w4)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Gemcitabine 1,500 mg/m² on days 1 and 8 of each 21-day cycle (2w3)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 174
Study: 11812915

Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO, epoetin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 9428213

Group type: EXPERIMENTAL
Intervention: Balsalazide (6.75 g daily)
Number of subjects: 101
Study: 7554207

Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 287

Group type: COMPARATOR
Intervention: Pump-prime-only aprotinin
Number of subjects: 287

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 287
Study: 2167008

Group type: EXPERIMENTAL
Intervention: Nonoxynol 9 (spermicide)
Number of subjects: 818

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 818
Study: 6992010

Group type: EXPERIMENTAL
Intervention: Etidocaine HCl (Duranest) 1%
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lidocaine HCl (Xylocaine) 2% with epinephrine 1:200,000
Number of subjects: 50
Study: 31608448

Group type: EXPERIMENTAL
Intervention: Probiotic combination
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 30975498

Group type: EXPERIMENTAL
Intervention: Reinforced stapler
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ultrasonic dissector
Number of subjects: 200
Study: 28422779

Group type: EXPERIMENTAL
Intervention: Simulation-based training
Number of subjects: 21

Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 21
Study: 27044782

Group type: EXPERIMENTAL
Intervention: Ultrasound simulation (SonoSim)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Hands-on training with live models
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 24439092

Group type: EXPERIMENTAL
Intervention: NeuroModulation Technique (NMT) - two sessions a week for six weeks
Number of subjects: 18

Group type: COMPARATOR
Intervention: Wait-list control group - two sessions a week for six weeks after the wait period
Number of subjects: 18
Study: 22906581

Group type: EXPERIMENTAL
Intervention: Hotz plate treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: No Hotz plate treatment
Number of subjects: 30
Study: 19064373

Group type: EXPERIMENTAL
Intervention: Calcium and Vitamin D Supplementation (active)
Number of subjects: 36282

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 36282
Study: 17324249

Group type: EXPERIMENTAL
Intervention: R667 0.2 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: R667 0.5 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: R667 1 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15606516

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with narrow filter (580-650 nm) at fluence rate of 30 mW cm(‐2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with narrow filter (580-650 nm) at fluence rate of 45 mW cm(‐2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with broad filter (580-690 nm) at fluence rate of 50 mW cm(‐2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with broad filter (580-690 nm) at fluence rate of 75 mW cm(‐2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with cumulative light dose of 40 J cm(‐2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with varying fluence rates from 30 to 75 mW cm(‐2)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with cumulative light dose of 20 J cm(‐2)
Number of subjects: 37
Study: 11688021

Group type: EXPERIMENTAL
Intervention: Intra Mobiele Zylinder implants (IMZ group, n = 41)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Brånemark implants (Brå group, n = 17)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Transmandibular Implant (TMI group, n = 29)
Number of subjects: 87

Group type: COMPARATOR
Intervention: IMZ and Brånemark implants
Number of subjects: 87
Study: 9844984

Group type: EXPERIMENTAL
Intervention: Children with complex partial epilepsy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal children
Number of subjects: 30
Study: 8299783

Group type: EXPERIMENTAL
Intervention: Flutamide
Number of subjects: 53

Group type: COMPARATOR
Intervention: Spironolactone
Number of subjects: 53
Study: 2087977

Group type: EXPERIMENTAL
Intervention: Postaural aids with modified skeleton moulds
Number of subjects: 0

Group type: COMPARATOR
Intervention: Temporary tips or standard skeletons
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-the-ear aids
Number of subjects: 0
Study: 393027

Group type: EXPERIMENTAL
Intervention: Enterobiotic (antibiotic prophylaxis)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis)
Number of subjects: 134
Study: 30484016

Group type: EXPERIMENTAL
Intervention: Catgut embedding
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 510

Group type: COMPARATOR
Intervention: Medication
Number of subjects: 510
Study: 28295766

Group type: EXPERIMENTAL
Intervention: Veterinarian-administered otic gel (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Owner-administered treatment (Group B)
Number of subjects: 50
Study: 25467586

Group type: EXPERIMENTAL
Intervention: AF-219, 600 mg twice a day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 23636409

Group type: EXPERIMENTAL
Intervention: Intraventricular recombinant tissue plasminogen activator (rt-PA) combined with external ventricular drainage (EVD)
Number of subjects: 19

Group type: COMPARATOR
Intervention: External ventricular drainage (EVD) alone
Number of subjects: 19
Study: 20615594

Group type: EXPERIMENTAL
Intervention: Hi-TENS combined with PCA-morphine
Number of subjects: 42

Group type: COMPARATOR
Intervention: PCA-morphine alone
Number of subjects: 42
Study: 19203821

Group type: EXPERIMENTAL
Intervention: Without metronome guidance
Number of subjects: 44

Group type: COMPARATOR
Intervention: With metronome guidance (100 bpm)
Number of subjects: 44
Study: 16462013

Group type: EXPERIMENTAL
Intervention: Impedance spectroscopy in group 3 (more than 4h of ischemia and complications)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Impedance spectroscopy in group 1 (no ischemia or complications)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Impedance spectroscopy in group 2 (short ischemia < 2h)
Number of subjects: 63
Study: 15370790

Group type: EXPERIMENTAL
Intervention: Health pessimists
Number of subjects: 456

Group type: COMPARATOR
Intervention: Good-health realists
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Health optimists
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Poor-health realists
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Discordance cases
Number of subjects: 456
Study: 11560127

Group type: EXPERIMENTAL
Intervention: ACTH-[1-24] (250 mg in 500 mL normal saline, infused at a constant rate over 8 h)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (normal saline only)
Number of subjects: 10
Study: 9592913

Group type: EXPERIMENTAL
Intervention: Electromyography on extensor muscles (extensor carpi radialis brevis and extensor digitorum)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Torque measurements and histologic observations from muscular and tendon biopsies
Number of subjects: 51
Study: 7843475

Group type: EXPERIMENTAL
Intervention: 12 plasma glucose and insulin determinations
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 26 plasma glucose and insulin determinations
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Reduction of blood samples from 26 to 12
Number of subjects: 16

Group type: COMPARATOR
Intervention: Glucose effectiveness
Number of subjects: 16
Study: 2662897

Group type: EXPERIMENTAL
Intervention: Interferon and descyclovir therapy
Number of subjects: 36

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Interferon therapy
Number of subjects: 36
Study: 4413468

Group type: EXPERIMENTAL
Intervention: Alpha biofeedback training for 1 hour
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (resting under similar conditions but given different instructions and no feedback)
Number of subjects: 21
Study: 31201041

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Oxygen (HFNO) at 50 L/min
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Bilevel Positive Airway Pressure (BIPAP) with pressure support 4 cmH2O
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard Oxygen Therapy (SOT) via a standard facemask
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: BIPAP with increased pressure support to 8 cmH2O
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: BIPAP with increased PEEP to 8 cmH2O
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: BIPAP with pressure support 8 cmH2O
Number of subjects: 50
Study: 28982202

Group type: EXPERIMENTAL
Intervention: Combined strength‐endurance training (CT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Physical activity education program (EDU)
Number of subjects: 28
Study: 25299520

Group type: EXPERIMENTAL
Intervention: 12-week supervised neuromuscular and strength exercise program
Number of subjects: 82

Group type: COMPARATOR
Intervention: Arthroscopic partial meniscectomy
Number of subjects: 82
Study: 23085134

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg orally)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21266003

Group type: EXPERIMENTAL
Intervention: Lidocaine plus morphine sulfate
Number of subjects: 34

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 34